Amidst the COVID-19 pandemic, there has been an evident surge in the demand for high quality cell therapies intended for research and therapeutic purposes, presenting lucrative opportu
Roots Analysis
Roots Analysis
Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, re
Biologics represent the cutting edge of medical research, offering hope to patients with clinical conditions that were previously considered incurable; 6 of the top 10 best selling drugs are biotherapeutic
Owing to the numerous benefits offered by biologics, this drug class has become an integral part of the overall pharmaceutical industry, having captured a signific
The surge in demand for COVID-19 vaccines has presented lucrative opportunities for both innovators and contract
Roots Analysis has announced the addition of
Roots Analysis has announced the addition
In order to determine the relative competitiveness of biopreservation media providers, we focused on several relevant parameters, such as, product portfolio strength (in terms of number of biopreservation media offered, preservation condition, presence of serum, type of biological sample, max
During our research, we identified 31 pre-installed single-use sensors developed by various companies for bioprocessing.
To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this -
During our research, we came across 105 service providers that are presently engaged in providing teleradiology services. The domain is currently dominated by small (40%) and mid-sized players (33%).
In the pharmaceutical industry, stakeholders are known to adopt a variety partnership models. Such initiatives not only allow the companies to expand their respective product / therapy, but also to gain additional capabilit
In order to keep pace with ongoing advances related to materials and regulatory scenarios, and to facilitate the cell therapy manufacturing process, cell therapy consumable providers are steadily evolving